News Releases

CODEBASE VENTURES INC. UPDATES ADVANCEMENT ON HYDROXYCHLOROQUINE STRATEGY

May 11, 2020 6:00 AM
Read more

CODEBASE INVESTMENT WORLD HIGH LIFE UPDATES SALES GROWTH OF WHOLLY OWNED SUBSIDIARY LOVE HEMP IN THE UK

May 08, 2020 6:00 AM
Read more

CODEBASE VENTURES INC. ANNOUNCES SECOND CLOSING OF FINANCING

May 05, 2020 3:25 PM
Read more

CODEBASE INVESTMENT ADDS ORAL MUCOSAL PATENT FILING, EXPANDING TRANSDERMAL TREATMENTS

April 23, 2020 12:01 AM
Read more

HYDROXYCHLOROQUINE SIDE EFFECTS POTENTIALLY MITIGATED BY TRANSDERMAL DELIVERY

April 21, 2020 12:05 AM
Read more

HYDROXYCHLOROQUINE TREATMENT FOR COVID-19 BENEFITS SOUGHT IN GLOBAL RESEARCH EFFORT TO ESTABLISH EFFICACY

April 20, 2020 6:30 AM
Read more

CODEBASE VENTURES INC. ANNOUNCES $1.5 MILLION FINANCING AND FIRST CLOSING OF FINANCING

April 16, 2020 2:30 PM
Read more

CODEBASE TO INVEST IN COMPANY DEVELOPING HYDROXYCHLOROQUINE TRANSDERMAL TREATMENT

April 16, 2020 12:01 AM
Read more

CODEBASE PROVIDES UPDATE ON ITS HOLDINGS AND NEAR-TERM INVESTMENT PRIORITIES

April 03, 2020 12:05 AM
Read more

CODE VENTURES INC. EXTENDS EXPIRY DATE OF CERTAIN WARRANTS

March 05, 2020 1:00 PM
Read more
Codebase Ventures Portfolio Company News Contact Legal Disclaimer